The Requirement for DNAM-1, NKG2D, and NKp46 in the Natural Killer Cell-Mediated Killing of Myeloma Cells

Cancer Research - United States
doi 10.1158/0008-5472.can-06-4230
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

DNAM-1: Would the Real Natural Killer Cell Please Stand Up!

Oncotarget
Oncology
2015English

Human microRNA-1245 Down-Regulates the NKG2D Receptor in Natural Killer Cells and Impairs NKG2D-mediated Functions

Haematologica
Hematology
2012English

Proteasome Inhibition Induces Apoptosis in Primary Human Natural Killer Cells and Suppresses NKp46-mediated Cytotoxicity

Haematologica
Hematology
2009English

Costimulatory Molecule DNAM-1 Is Essential for Optimal Differentiation of Memory Natural Killer Cells During Mouse Cytomegalovirus Infection

Immunity
Infectious DiseasesAllergyImmunology
2014English

Enhancing Natural Killer Cell-Mediated Lysis of Lymphoma Cells by Combining Therapeutic Antibodies With CD20-Specific Immunoligands Engaging NKG2D or NKp30

Blood
BiochemistryImmunologyCell BiologyHematology
2014English

Natural Cytotoxicity Triggering Receptor 1 (NCR1; NKP46; CD335); Natural Killer P30 Receptor (NKp30; NCR3; CD337)

Science-Business eXchange
2012English

NKG2D-mediated Natural Killer Cell Protection Against Cytomegalovirus Is Impaired by Viral Gp40 Modulation of Retinoic Acid Early Inducible 1 Gene Molecules

Journal of Experimental Medicine
MedicineAllergyImmunology
2003English

Circulating NKp46+ Natural Killer Cells Have a Potential Regulatory Property and Predict Distinct Survival in Non-Small Cell Lung Cancer

OncoImmunology
OncologyAllergyImmunology
2018English

Adoptive Transfer of NKG2D CAR mRNA-Engineered Natural Killer Cells in Colorectal Cancer Patients

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy